Th17 cells can stimulate CD8 + CTL response through IL-2 and pMHC I, and stimulate the expression of CCL2 and CCL20 in tumor microenvironment to promote the recruitment of various inflammatory leukocytes (DCs, CD4 + and CD8+ T cells) (34). The gene discussed is CCL2; the disease is neoplasm.